Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Chemsex and recreational drug use news


From To
Australia's Therapeutic Goods Administration decides not to ban poppers

Australia’s Therapeutic Goods Administration (TGA) has been praised for backing down on an outright ban of “poppers”.

10 June 2019
Hepatitis C more stigmatising than HIV: gay men’s attitudes towards hepatitis C reinfection

Qualitative research with HIV-positive gay and bisexual men in Australia who had been cured of hepatitis C infection revealed that having hepatitis C was more stigmatising than

04 June 2019
Krishen Samuel
One third of French HIV group uses illicit drugs, often risking antiretroviral interactions

One in 3 people in a 286-person French HIV group took illicit drugs that sometimes posed a risk of severe interactions with antiretrovirals. Many potential interactions involved the boosting agents ritonavir or cobicistat.

17 May 2019
Decline in chemsex over time in three English clinics

In the first study to track chemsex over time, the number of men having chemsex fell by two-thirds between 2015 and 2018, Janey Sewell and

09 May 2019
Roger Pebody
English clinic survey finds that 40% of gay men with new hepatitis C infections are HIV negative

A study of gay and bisexual men diagnosed with recently acquired hepatitis C infection and treated in three English clinics has found that 40% of them were

07 April 2019
Gus Cairns
Drugs before sex more common in UK than in Europe or US – study

UK citizens are more likely than Europeans or those living in the US to have taken drugs such as MDMA and cocaine before sex during the last year, according to a new study.

02 April 2019
The Guardian
Effect of Depression, Lifestyle on Cognitive Function in PLWHIV

Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.

26 March 2019
Infectious Disease Advisor
Ireland: The new HIV crisis needs a better response

HIV is a public heath issue, but a spike in diagnoses in Ireland seems to be going unchecked. New figures published last week show there were 531 new cases of HIV infections diagnosed in 2018, an increase from 492 in 2017. There is now a new diagnosis of HIV in Ireland every 17 hours; Ireland’s rate of new diagnoses stood at 10.2 per 100,000 people in 2017, while the European average is 6.2 per 100,000.

04 March 2019
Irish Times
Cocaine use associated with poor adherence to PrEP and dropping out of care

Cocaine users have poorer adherence to HIV pre-exposure prophylaxis (PrEP) and engagement with care, according to research published in the online edition of the Journal of Acquired

22 February 2019
Michael Carter
Smoking cannabis is an independent risk factor for lung disease in people with HIV

Frequent cannabis smoking is a risk factor for lung disease in HIV-positive men, according to US research published in EClinicalMedicine. Smoking cannabis increased the risk of pulmonary diseases

15 February 2019
Michael Carter
← First12345...42Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.